Search

Illumina Inc

Aperta

SettoreSettore sanitario

221.47 4.21

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

210.31

Massimo

217.52

Metriche Chiave

By Trading Economics

Entrata

-268M

-134M

Vendite

68M

1.2B

P/E

Media del settore

39.782

56.659

EPS

1.31

Margine di Profitto

-11.562

Dipendenti

8,600

EBITDA

80M

330M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

-7.41% downside

Dividendi

By Acuity

Utili prossimi

29 ott 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

3.6B

32B

Apertura precedente

217.26

Chiusura precedente

221.47

Notizie sul Sentiment di mercato

By Acuity

5%

95%

3 / 340 Classifica in Healthcare

Illumina Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

2 set 2026, 22:56 UTC

Illumina Inc's shares are higher in after-market hours following Wednesday's close, maintaining a position above its 20-day moving average. No specific news was identified.

1 set 2026, 20:09 UTC

Illumina Inc's shares are lower today, continuing a downward trend observed since Monday. The stock has reached a session low, marking a third consecutive decline.

31 ago 2026, 23:36 UTC

Illumina Inc. shares declined in after-market trading, following hawkish comments from Federal Reserve Chair Kevin Warsh that affected market sentiment.

28 ago 2026, 23:16 UTC

Illumina Inc's shares are higher in after-market trading, reflecting positive momentum since Friday's close and routine trading activity within a narrow range.

27 ago 2026, 20:07 UTC

Illumina Inc shares are higher during Thursday's session, supported by a decline in initial jobless claims, though no specific company news was identified.

26 ago 2026, 20:07 UTC

News

Illumina Inc shares are lower today amid a broader downturn in the Life Sciences Tools & Services sub-sector. Analysts estimate fair value at $172.53.

25 ago 2026, 20:07 UTC

News

Illumina Inc shares are advancing as investor sentiment improves ahead of a meeting with Piper Sandler scheduled for August 27.

24 ago 2026, 20:02 UTC

Social Media
News

Illumina Inc reported second-quarter earnings of $1.31 per share, with revenue of $1.16 billion, surpassing estimates. Shares are advancing during Monday's session.

21 ago 2026, 19:16 UTC

Illumina Inc shares are higher today, recovering from earlier losses and remaining above the 20-day moving average for the third consecutive session.

20 ago 2026, 20:02 UTC

Illumina Inc's shares are higher today, building on gains since Wednesday. The stock is trading near the upper end of its one-month range.

19 ago 2026, 20:02 UTC

Correlated Moves

Illumina Inc. shares are higher, buoyed by strong momentum in the genomics sector and a notable rise in the ARK Genomic Revolution ETF.

17 ago 2026, 19:54 UTC

News

Illumina Inc's stock is higher, supported by a Yahoo Finance article discussing its price target of $198.89 and concerns over organic sales performance.

13 ago 2026, 20:06 UTC

Illumina Inc's shares are lower amid declines in the Life Sciences Tools & Services sector, with no specific company news identified for the movement.

12 ago 2026, 22:02 UTC

Illumina Inc shares are lower in after-market hours with no specific news identified. Broader market conditions reflect mixed performance amid inflation data.

11 ago 2026, 19:16 UTC

Illumina Inc. shares are trading higher, recovering from an early dip during Tuesday's session. No specific news or developments were identified.

10 ago 2026, 23:16 UTC

Correlated Moves

Illumina Inc shares fell in after-hours trading, tracking a broader decline in the Russell 2000 Index amid rising U.S. Treasury yields and inflation concerns.

7 ago 2026, 19:46 UTC

News

Illumina Inc shares are lower after Director Keith A. Meister sold 283,269 shares, raising investor concerns about the company's valuation.

6 ago 2026, 23:06 UTC

Illumina Inc shares are lower in after-market trading following Thursday's close, despite an initial uptick. No specific news was identified to explain the decline.

5 ago 2026, 19:52 UTC

Correlated Moves

Illumina shares are lower following disappointing first-quarter results and broader market declines. ADP's report on weak job growth has added to cautious sentiment.

4 ago 2026, 19:31 UTC

Correlated Moves

Illumina Inc's shares are higher today, reflecting a broader market trend as the Russell 2000 Index also advances. The stock is near its one-month range high.

3 ago 2026, 20:03 UTC

News

Illumina shares are lower today as Citigroup maintains a Sell rating and raises its price target to $113 amid mixed analyst sentiment.

31 lug 2026, 23:06 UTC

News

Illumina Inc reported strong Q2 results and raised full-year guidance, yet shares declined in after-market trading from Friday's close of $202.95.

30 lug 2026, 23:41 UTC

News
Social Media

Illumina Inc shares declined in after-market trading despite strong second-quarter results and raised full-year EPS guidance, reflecting concerns over falling net income.

29 lug 2026, 23:26 UTC

Illumina Inc. shares declined after-market amid overall market volatility following the Federal Reserve's decision to maintain interest rates amid rising inflation concerns.

28 lug 2026, 19:46 UTC

News

Illumina Inc. is acquiring contingent payments from its merger with Treeline Biosciences to enhance integration. Shares are trading higher since Monday's close.

27 lug 2026, 23:26 UTC

Illumina Inc shares are lower in after-market hours, continuing a decline over the past three sessions with no specific news identified.

24 lug 2026, 17:46 UTC

Illumina Inc's shares are lower today, hitting a mid-morning low. Broader market sentiment may be affected by recent volatility in oil prices.

22 lug 2026, 19:31 UTC

News

Illumina Inc shares are lower amid a report citing stagnant sales and concerns over management's investment opportunities. The company may need acquisitions for growth.

21 lug 2026, 20:02 UTC

Correlated Moves
News

Illumina Inc's shares are higher, supported by broader market momentum and anticipation of upcoming earnings from major companies. The Russell 2000 Index also advanced.

20 lug 2026, 19:56 UTC

Correlated Moves

Illumina Inc shares declined during Monday's session, paralleling a drop in the ARK Genomic Revolution ETF amid broader market weakness.

Confronto tra pari

Modifica del prezzo

Illumina Inc Previsione

Obiettivo di Prezzo

By TipRanks

-7.41% in calo

Previsioni per 12 mesi

Media 197.44 USD  -7.41%

Alto 235 USD

Basso 113 USD

Basato su 16 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Illumina Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

16 ratings

8

Acquista

5

Mantieni

3

Vendi

Sentiment

By Acuity

3 / 340 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Illumina Inc

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.
help-icon Live chat